| Literature DB >> 31805150 |
Flávia Afonso Lima1, André Barateiro1, Jamille Gregório Dombrowski1, Rodrigo Medeiros de Souza2, Douglas de Sousa Costa1, Oscar Murillo1, Sabrina Epiphanio3, Lígia Antunes Gonçalves1, Claudio Romero Farias Marinho1.
Abstract
Plasmodium (P.) falciparum malaria during pregnancy has been frequently associated with severe consequences such as maternal anemia, abortion, premature birth, and reduced birth weight. Placental damage promotes disruption of the local homeostasis; though, the mechanisms underlying these events are still to be elucidated. Autophagy is a fundamental homeostatic mechanism in the natural course of pregnancy by which cells self-recycle in order to survive in stressful environments. Placentas from non-infected and P. falciparum-infected women during pregnancy were selected from a previous prospective cohort study conducted in the Brazilian Amazon (Acre, Brazil). Newborns from infected women experienced reduced birth weight (P = 0.0098) and placental immunopathology markers such as monocyte infiltrate (P < 0.0001) and IL-10 production (P = 0.0122). The placentas were evaluated for autophagy-related molecules. As a result, we observed reduced mRNA levels of ULK1 (P = 0.0255), BECN1 (P = 0.0019), and MAP1LC3B (P = 0.0086) genes in placentas from P. falciparum-infected, which was more striking in those diagnosed with placental malaria. Despite the protein levels of these genes followed the same pattern, the observed reduction was not statistically significant in placentas from P. falciparum-infected women. Nevertheless, our data suggest that chronic placental immunopathology due to P. falciparum infection leads to autophagy dysregulation, which might impair local homeostasis during malaria in pregnancy that may result in poor pregnancy outcomes.Entities:
Year: 2019 PMID: 31805150 PMCID: PMC6894763 DOI: 10.1371/journal.pone.0226117
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of pregnant women enrolling the study according to infection status.
| NON-INFECTED | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Characteristics, median (IQR) | n | n | n | n | |||||||
| Obstetric | |||||||||||
| | 24.00 (18.00–28.50) | 45 | 23.00 (17.00–28.00) | 43 | 0.7812 | 23.00 (20.00–28.00) | 15 | >0.9999 | 21.50 (17.00–27.75) | 28 | >0.9999 |
| | 1.00 (1.00–3.00) | 45 | 2.00 (1.00–3.00) | 39 | 0.9484 | 2.00 (1.00–2.75) | 12 | >0.9999 | 1.00 (1.00–3.25) | 26 | >0.9999 |
| | 39.00 (39.00–40.00) | 45 | 39.00 (38.00–40.00) | 43 | 0.2728 | 39.00 (38.00–40.00) | 15 | >0.9999 | 39.00 (38.00–40.00) | 28 | 0.8504 |
| | 21.51 (20.45–25.51) | 44 | 20.58 (19.47–22.26) | 40 | 20.97 (19.46–22.29) | 15 | 0.4289 | 20.32 (19.39–22.33) | 25 | ||
| | 592.60 (519.20–661.80) | 45 | 545.20 (488.20–587.10) | 39 | 527.70 (488.20–569.30) | 15 | 0.1022 | 564.80 (477.3–614.90) | 25 | 0.4315 | |
| | 3.25 (3.03–3.69) | 45 | 3.12 (2.93–3.35) | 43 | 3.12 (2.93–3.32) | 15 | 0.3006 | 3.16 (2.92–3.40) | 28 | 0.2412 | |
| | 5.71 (5.05–6.01) | 44 | 5.76 (5.32–6.17) | 40 | 0.3449 | 5.70 (5.62–6.12) | 15 | 0.7363 | 5.66 (5.13–6.22) | 26 | >0.9999 |
| | |||||||||||
| | 100 | 45 | 39.53 | 17 | ND | 100 | 15 | ND | 7.14 | 2 | ND |
| | 0 | 0 | 32.56 | 14 | ND | 0 | 0 | ND | 50.00 | 14 | ND |
| | 0 | 0 | 27.91 | 12 | ND | 0 | 0 | ND | 42.86 | 12 | ND |
| | 0 | 0 | 0 | 0 | ND | 0 | 0 | ND | 0 | 0 | ND |
| | 12.00 (9.00–15.00) | 44 | 14.00 (11.00–20.00) | 43 | 12.00 (8.00–16.00) | 15 | >0.9999 | 16.50 (12.00–21.75) | 28 | ||
| | 1.92 (1.83–2.42) | 45 | 2.00 (1.92–2.83) | 43 | 0.0777 | 1.92 (1.92–2.75) | 15 | >0.9999 | 2.17 (1.92–2.90) | 28 | 0.0547 |
| | 6.77 (4.29–9.98) | 45 | 7.96 (5.26–9.96) | 43 | 0.8465 | 8.55 (5.35–9.96) | 15 | >0.9999 | 7.13 (4.29–9.94) | 28 | >0.9999 |
| | 4.00 (3.40–4.70) | 43 | 4.40 (3.60–4.95) | 38 | 0.1354 | 4.35 (3.42–5.20) | 12 | >0.9999 | 4.40 (3.68–4.95) | 26 | 0.3011 |
| | 13.00 (9.00–19.00) | 42 | 20.00 (12.00–31.75) | 42 | 19.00 (12.00–35.00) | 15 | 21.00 (11.00–31.00) | 27 | |||
| | 4.00 (1.00–6.00) | 42 | 7.00 (5.00–16.00) | 41 | 7.00 (5.00–16.00) | 15 | 7.00 (5.00–14.00) | 27 | |||
| | 3.92 (3.10–4.33) | 45 | 3.60 (3.36–4.02) | 39 | 0.4350 | 3.72 (2.68–4.02) | 15 | >0.9999 | 3.59 (3.40–4.23) | 24 | >0.9999 |
| | 24.42 (14.50–44.22) | 39 | 24.68 (15.55–52.29) | 36 | 0.4682 | 22.66 (14.09–35.36) | 14 | >0.9999 | 31.48 (16.95–79.63) | 22 | 0.5477 |
| | 5.46 (4.62–6.42) | 44 | 5.27 (4.58–6.04) | 35 | 0.4190 | 4.95 (3.80–5.90) | 14 | 0.5392 | 4.40 (4.71–6.17) | 21 | >0.9999 |
| | 3.66 (3.06–4.83) | 42 | 4.61 (3.48–5.79) | 36 | 4.69 (3.29–5.46) | 15 | 0.3244 | 4.53 (3.66–6.40) | 21 | 0.0583 | |
| | 61.33 (21.94–102.30) | 36 | 64.33 (27.55–157.60) | 37 | 0.2926 | 40.29 (16.99–101.30) | 13 | >0.9999 | 102.90 (40.73–169.20) | 23 | 0.2307 |
| | 4.88 (4.17–5.60) | 42 | 4.73 (3.71–5.71) | 36 | 0.4803 | 4.14 (3.68–6.01) | 15 | 0.7369 | 4.88 (3.96–5.74) | 22 | >0.9999 |
P. falciparum-INFECTED PM-, Plasmodium falciparum-infected pregnant women with placental malaria negative; P. falciparum-INFECTED PM+, Plasmodium falciparum-infected pregnant women with placental malaria positive; IQR, interquartile range; n, number of individuals. Bold values depict P values < 0.05.
# Differences between NON-INFECTED and P. falciparum-INFECTED were evaluated using the Student’s t-test when data set fit normality after application of proper normality test.
† Differences between NON-INFECTED and P. falciparum-INFECTED were evaluated using Mann-Whitney rank sum test when data sets did not fit normality, after application of proper normality test.
* Differences between NON-INFECTED and P. falciparum-INFECTED PM- or P. falciparum-INFECTED PM+ were evaluated using the non-parametric Kruskal-Wallis test with Dunn’s post-test.